A SERS-active plasmonic nanosensor-chemometrics platform reveals a biphasic zinc switch that controls breast-cancer metastasis
Biosensors and Bioelectronics · 2025
DOI: 10.1016/j.bios.2025.117897 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2025. Verfasst von Ting Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Integrative Biomedical Materials and Nanomedicine Laboratory, Medicine and Life Sciences Department, Universitat Pompeu Fabra, Carrer Del Doctor Aigu…. Hauptthemen laut MEDLINE: Zinc, Breast Neoplasms, Biosensing Techniques. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministerio de Ciencia y Tecnología, Government of Catalonia Agency for Administration of University and Research Grants, China Scholarship Council.
Abstract (Originalsprache)
Labile Zn2+ is emerging as a quantitative driver, not just a biomarker, of metastasis, yet rapid, second-resolved intracellular measurement remains elusive. Here we engineer terpyridine-functionalised, hollow Au@SiO2 nanocapsules (NCs@TPY) and couple their SERS signal to cell-specific partial-least-squares (PLS) chemometrics, yielding an 8-log dynamic range (10-12 - 10-4 M), a low-nanomolar detection limit and ≤4.5 % cross-validated error while rejecting Ca2+/Mg2+ interference. Applying this platform to four breast-cancer lines reveals that basal cytosolic Zn2+ forms a "ladder" paralleling metastatic aggressiveness (MCF-7 25 pM < MDA 430 pM < LM2 4.7 nM < BrM2 51 nM). Manipulating extracellular zinc uncovers a biphasic switch: migration, invasion and proliferation all peak when intracellular Zn2+ rises into the nanomolar band (∼10-560 nM) and collapse once it exceeds ∼5-70 μM (line-specific). Primary-tumour-derived MDA cells are hypersensitive, reaching maximal metastatic traits at ∼0.6 μM Zn2+, whereas lung- and brain-tropic variants show partial resistance, indicating micro-environmental adaptation. The NCs@TPY-PLS assay thus provides the first tool to track intracellular zinc across eight orders of magnitude in situ and demonstrates that tightly regulated Zn2+ dyshomeostasis controls metastatic behaviour. Because the Raman ligand is exchangeable, the capsule architecture is readily extendable to multiplex ion or redox sensing, and the identified "functional window" positions zinc transporters as actionable targets for anti-metastatic therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Integrative Biomedical Materials and Nanomedicine Laboratory, Medicine and Life Sciences Department, Universitat Pompeu Fabra, Carrer Del Doctor Aiguader 88, 08003, Barcelona, Spain.
- Chemometrics and Sensorics for Analytical Solutions (CHEMOSENS) Group, Department of Analytical and Organic Chemistry, Rovira I Virgili University, Marcel·lí Domingo S/n, 43007, Tarragona, Spain.
- Integrative Biomedical Materials and Nanomedicine Laboratory, Medicine and Life Sciences Department, Universitat Pompeu Fabra, Carrer Del Doctor Aiguader 88, 08003, Barcelona, Spain. Electronic address: pilar.rivera@upf…
Förderung
- Ministerio de Ciencia y Tecnología
- Government of Catalonia Agency for Administration of University and Research Grants
- China Scholarship Council
- Spain Ministry of Science and Innovation
Zitieren
APA
Zhou, T., Rodríguez-Barrios, S., Ruisánchez, I., & Rivera-Gil, P. (2025). A SERS-active plasmonic nanosensor-chemometrics platform reveals a biphasic zinc switch that controls breast-cancer metastasis. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2025.117897
Vancouver
Zhou T, Rodríguez-Barrios S, Ruisánchez I, Rivera-Gil P. A SERS-active plasmonic nanosensor-chemometrics platform reveals a biphasic zinc switch that controls breast-cancer metastasis. Biosensors and Bioelectronics. 2025. doi:10.1016/j.bios.2025.117897
BibTeX
@article{Zhou2025,
author = {Zhou, Ting and Rodríguez-Barrios, Suliany and Ruisánchez, Itziar and Rivera-Gil, Pilar},
title = {A SERS-active plasmonic nanosensor-chemometrics platform reveals a biphasic zinc switch that controls breast-cancer metastasis},
journal = {Biosensors and Bioelectronics},
year = {2025},
doi = {10.1016/j.bios.2025.117897}
}
EUVIMED